Follow Melissa Palmer, MD, FAASLD
Follow Melissa Palmer, MD, FAASLD
Make a free account and we’ll email you when they’re booked to speak, or their slides or recordings are posted.
Get an email when they’re booked to speak.
Melissa Palmer, MD, FAASLD
CEO Liver Consulting LLC
Melissa Palmer, MD has been a Hepatologist for over 35 years and is an experienced biotech/pharma executive. She is currently CEO of Liver Consulting LLC, consulting exclusively to biotech and pharmaceutical companies on hepatology-related issues such as: innovative trial designs for all liver diseases including metabolic dysfunction-associated steatotic hepatitis (MASH), PBC, Hepatitis B and D, primary sclerosing cholangitis (PSC), alcohol- associated liver disease and all aspects of liver disease drug development from pre-IND to NDA. Dr Palmer's specific expertise is in hepatotoxicity, DILI, hepatic adverse event adjudication and hepatic signal evaluation during clinical trials.
4 talks · 1 event
Speaking
2026
-
Nov 5–9